Episode Details

Trigger Warning: this episode discusses cancer, cancer diagnosis, cancer treatment and mastectomy.

Bonus Episode

Description: In this powerful episode, Naman Julka-Anderson and Jo McNamara features the incredible Professor Joanna Callaghan is a filmmaker and Professor of Filmmaking at the University of Sussex. Known for her boundary-pushing storytelling and distinctive approach to personal subjects, her work explores themes of resilience, transformation and the creative human spirit. Goodbye Breasts! marks an important new chapter in her artistic practice.

In this personal episode, Naman Julka-Anderson and Jo McNamara hear about Joanna’s career, cancer treatment, body confidence and Goodbye Breasts! documentary. 

CPD Reflection Points:

1. Reflect on your perceptions around body confidence and the impact that cancer can have.
2. Consider the impact of having a genetic mutation.
3. Consider the psychosocial and psychosexual impact of having a mastectomy.

Complete this form for your accredited digital badge: Digital Badge Form.

Links from the Episode:

• Goodbye Breasts!
• Surgery for primary breast cancer
• PALB2 Gene: Understanding the Mutation & Cancer Risks
• National Genomics Education Programme - PALB2
• CoppaFeel! Check Your Chest

Research links from the Episode:

• Examination of body image perception and quality of life of women with segmental or total mastectomy: a cross-sectional study
• Body image and psychosocial effects in women after treatment of breast cancer: A prospective study
• Breast-Cancer Risk in Families with Mutations in PALB2

Rad Chat Links:

• Rad Chat Website
• Link Tree
• Facebook
• Instagram
• LinkedIn
• TikTok
• BlueSky
• YouTube

Credits: Music and jingle credits: Dr. Ben Potts and Adam Cooke.

© Rad Chat 2025. All rights reserved.  

We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  

You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.